222 related articles for article (PubMed ID: 33140232)
1. Pharmaceutical Compounding: a History, Regulatory Overview, and Systematic Review of Compounding Errors.
Watson CJ; Whitledge JD; Siani AM; Burns MM
J Med Toxicol; 2021 Apr; 17(2):197-217. PubMed ID: 33140232
[TBL] [Abstract][Full Text] [Related]
2. Potential risks of pharmacy compounding.
Gudeman J; Jozwiakowski M; Chollet J; Randell M
Drugs R D; 2013 Mar; 13(1):1-8. PubMed ID: 23526368
[TBL] [Abstract][Full Text] [Related]
3. Regulating compounding pharmacies after NECC.
Outterson K
N Engl J Med; 2012 Nov; 367(21):1969-72. PubMed ID: 23134357
[No Abstract] [Full Text] [Related]
4. Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy.
Pinkerton JV; Pickar JH
Menopause; 2016 Feb; 23(2):215-23. PubMed ID: 26418479
[TBL] [Abstract][Full Text] [Related]
5. U.S. Compounding Pharmacy-Related Outbreaks, 2001-2013: Public Health and Patient Safety Lessons Learned.
Shehab N; Brown MN; Kallen AJ; Perz JF
J Patient Saf; 2018 Sep; 14(3):164-173. PubMed ID: 26001553
[TBL] [Abstract][Full Text] [Related]
6. Coagulation and adulteration--building on science and policy lessons from 1905.
Avorn J
N Engl J Med; 2008 Jun; 358(23):2429-31. PubMed ID: 18525040
[No Abstract] [Full Text] [Related]
7. Compounding interest: a tragedy caused by contaminated steroids turned the spotlight on compounding pharmacies.
Hinkley KN
State Legis; 2013 Jun; 39(6):22-3. PubMed ID: 23805443
[No Abstract] [Full Text] [Related]
8. The right to a trial: Should dying patients have access to experimental drugs?
Groopman J
New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
[No Abstract] [Full Text] [Related]
9. Compounding pharmacy conundrum: "we cannot live without them but we cannot live with them" according to the present paradigm.
Guharoy R; Noviasky J; Haydar Z; Fakih MG; Hartman C
Chest; 2013 Apr; 143(4):896-900. PubMed ID: 23412546
[TBL] [Abstract][Full Text] [Related]
10. Patient safety issues associated with the use of compounded medicines as alternatives to approved pharmaceutical products in Europe and how best practice can improve outcomes.
Isles M
Int J Risk Saf Med; 2020; 31(3):133-144. PubMed ID: 32538874
[TBL] [Abstract][Full Text] [Related]
11. [Oral and formulated pharmaceutical preparations before the invention of tablets].
Bartók A
Orvostort Kozl; 2009; 55(1-4):171-82. PubMed ID: 20481112
[TBL] [Abstract][Full Text] [Related]
12. [The industrialisation of therapeutic agents: a story of practices between science, technology, medicine and the law].
Gaudillière JP
Gesnerus; 2007; 64(1-2):93-108. PubMed ID: 17982961
[No Abstract] [Full Text] [Related]
13. Ask your doctor: Justice Holmes and the marketplace of ideas.
Weissmann G
FASEB J; 2009 Dec; 23(12):4039-42. PubMed ID: 19948522
[No Abstract] [Full Text] [Related]
14. Sterile compounding: clinical, legal, and regulatory implications for patient safety.
Qureshi N; Wesolowicz L; Stievater T; Lin AT
J Manag Care Spec Pharm; 2014 Dec; 20(12):1183-91. PubMed ID: 25443512
[TBL] [Abstract][Full Text] [Related]
15. Toward Better-Quality Compounded Drugs - An Update from the FDA.
Woodcock J; Dohm J
N Engl J Med; 2017 Dec; 377(26):2509-2512. PubMed ID: 29281577
[No Abstract] [Full Text] [Related]
16. The history and contemporary challenges of the US Food and Drug Administration.
Borchers AT; Hagie F; Keen CL; Gershwin ME
Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
[TBL] [Abstract][Full Text] [Related]
17. Pharmacy compounding of high-risk level products and patient safety.
Mullarkey T
Am J Health Syst Pharm; 2009 Sep; 66(17 Suppl 5):S4-13. PubMed ID: 19710449
[TBL] [Abstract][Full Text] [Related]
18. Drugs through the ages.
Lasagna L
S Afr Med J; 1968 Mar; 42(9):198-202. PubMed ID: 4869718
[No Abstract] [Full Text] [Related]
19. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs.
Patsner B
Food Drug Law J; 2008; 63(2):459-91. PubMed ID: 18561473
[No Abstract] [Full Text] [Related]
20. Applying Quality by Design Concepts to Pharmacy Compounding.
Timko RJ
Int J Pharm Compd; 2015; 19(6):453-63. PubMed ID: 26891559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
